PARP1 and neoplasm: The antitumor effect of miR‐30e was further confirmed in vivo showing decreased tumor volume and tumor progression along with decreased expression of the proliferation marker Ki67, and increased expression of apoptotic marker‐cleaved PARP in our xenograft studies.